Dieu Ngo, MD
Surgery · Houston, TXNPI 1396724910
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Covidien LP at 34.6% of the total. Reporting peaked in 2019 at $5,665 and has fallen 86.7% since, to $753 in 2025.
Across 102 payments — averaging $140.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$5K
- Medtronic$3K
- AbbVie$2K
- TELA Bio, Inc.$2K
- Davol Inc.$626
- Intuitive Surgical$506
- plus $842 from 11 others
What the payments were for
- Consulting fees$5,05035%
- Travel & lodging$3,40424%
- Food & beverage$5,91141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 9 | $4,968 |
| Medtronic | 34 | $3,260 |
| AbbVie | 14 | $2,091 |
| TELA Bio, Inc. | 17 | $2,071 |
| Davol Inc. | 10 | $626 |
| Intuitive Surgical | 3 | $506 |
| Gilead | 2 | $222 |
| AstraZeneca | 2 | $218 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| W. L. Gore & Associates, Inc. | 1 | $75 |
| Biom'up France SAS | 1 | $45 |
| Hologic Sales And Service, LLC | 1 | $39 |
| Merck | 2 | $35 |
| Heron Therapeutics, Inc. | 2 | $28 |
| Medistim USA, Inc. | 1 | $23 |
| Kerecis Limited | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ProGrip$4,844
- VenaSeal$1,920
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,621
- NATRELLE SALINE-FILLED BREAST IMPLANTS$1,286
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$677
- REVOLVE$643
- Da Vinci Surgical System$487
- STRATTICE$369
- Palindrome$325
- Phasix Mesh$266
- Ovitex$151
- DUPIXENT$125
- FASENRA$122
- Vemlidy$106
- Dextile$100
How this compares
$14,365 in reported general payments places this provider in the 80th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Houston
- James SuliburkHouston$161K
- Funda MericHouston$141K
- Jonathan StahlHouston$105K
- Richard KnightHouston$103K
- Tanyaradzwa KajeseHouston$92K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.